CS logo
small CS logo
Illinois CancerCare-Carthage

Carthage, Illinois, United States
Doctor in Hancock County, Illinois
1450 N Co Rd 2050, Carthage, IL 62321

About Illinois CancerCare-Carthage


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
153
Alliance for Clinical Trials in Oncology
73
SWOG Cancer Research Network
57
ECOG-ACRIN Cancer Research Group
26
NRG Oncology
8
GOG Foundation
5
Gynecologic Oncology Group
5
NSABP Foundation Inc
5
Wake Forest University Health Sciences
5
Children's Oncology Group
2
Eastern Cooperative Oncology Group
2
Total Rows: 13

Clinical Trials at Illinois CancerCare-Carthage


During the past decade, Illinois CancerCare-Carthage conducted 176 clinical trials. In the 10-year time frame, 176 clinical trials started and 149 clinical trials were completed, i.e. on average, 84.7% percent of trials that started reached the finish line to date. In the past 5 years, 61 clinical trials started and 69 clinical trials were completed. i.e. 113.1% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years191915152222242435353535212155991111272715151818181824241717Started TrialsCompleted Trails2015201620172018201920202021202202040
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
1984-06-01
Active, not recruiting
9,000
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
2003-11-01
2027-01-01
Active, not recruiting
3,294
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
2004-09-01
2013-05-01
Completed
52
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
2005-03-01
2018-08-01
Completed
4,216
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
2006-03-01
2015-08-01
Completed
97
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
2005-07-26
2022-05-20
Completed
70

Rows per page:

1–100 of 343

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Illinois CancerCare-Carthage" #1 sponsor was "National Cancer Institute (NCI)" with 153 trials, followed by "Alliance for Clinical Trials in Oncology" with 73 trials sponsored, "SWOG Cancer Research Network" with 57 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 26 trials sponsored and "NRG Oncology" with 26 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 13 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois CancerCare-Carthage" #1 collaborator was "National Cancer Institute (NCI)" with 188 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator and "Cancer and Leukemia Group B" with 6 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 37 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 153National CancerInstitute (NCI): 153Alliance for ClinicalTrials in Oncology: 73Alliance for ClinicalTrials in Oncology: 73SWOG Cancer ResearchNetwork: 57SWOG Cancer ResearchNetwork: 57ECOG-ACRIN CancerResearch Group: 26ECOG-ACRIN CancerResearch Group: 26NRG Oncology: 8NRG Oncology: 8GOG Foundation: 5GOG Foundation: 5Gynecologic Oncology Group: 5Gynecologic Oncology Group: 5NSABP Foundation Inc: 5NSABP Foundation Inc: 5Wake Forest UniversityHealth Sciences: 5Wake Forest UniversityHealth Sciences: 5Children's Oncology Group: 2Children's Oncology Group: 2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 188National CancerInstitute (NCI): 188NRG Oncology: 27NRG Oncology: 27Canadian Cancer TrialsGroup: 12Canadian Cancer TrialsGroup: 12SWOG Cancer ResearchNetwork: 7SWOG Cancer ResearchNetwork: 7Cancer and LeukemiaGroup B: 6Cancer and LeukemiaGroup B: 6NCIC Clinical Trials Group: 6NCIC Clinical Trials Group: 6MillenniumPharmaceuticals, Inc.: 4MillenniumPharmaceuticals, Inc.: 4North Central CancerTreatment Group: 4North Central CancerTreatment Group: 4Eastern CooperativeOncology Group: 3Eastern CooperativeOncology Group: 3Radiation TherapyOncology Group: 2Radiation TherapyOncology Group: 2

Clinical Trials Conditions at Illinois CancerCare-Carthage


According to Clinical.Site data, the most researched conditions in "Illinois CancerCare-Carthage" are "Breast Cancer" (17 trials), "Stage IV Lung Cancer AJCC v8" (11 trials), "Invasive Breast Carcinoma" (10 trials), "Recurrent Breast Carcinoma" (10 trials) and "Recurrent Ovarian Carcinoma" (10 trials). Many other conditions were trialed in "Illinois CancerCare-Carthage" in a lesser frequency.

Clinical Trials Intervention Types at Illinois CancerCare-Carthage


Most popular intervention types in "Illinois CancerCare-Carthage" are "Drug" (277 trials), "Other" (208 trials), "Biological" (136 trials), "Procedure" (83 trials) and "Radiation" (51 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (93 trials), "Quality-of-Life Assessment" (80 trials), "Questionnaire Administration" (55 trials), "Computed Tomography" (42 trials) and "Biospecimen Collection" (40 trials). Other intervention names were less common.

Clinical Trials Genders at Illinois CancerCare-Carthage


The vast majority of trials in "Illinois CancerCare-Carthage" are 284 trials for "All" genders, 50 trials for "Female" genders and 9 trials for "Male" genders.

Clinical Trials Status at Illinois CancerCare-Carthage


Currently, there are NaN active trials in "Illinois CancerCare-Carthage". undefined are not yet recruiting, 89 are recruiting, 138 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 88 completed trials in Illinois CancerCare-Carthage, 9 suspended trials, and 16 terminated clinical trials to date.
Out of the total trials that were conducted in Illinois CancerCare-Carthage, 20 "Phase 1" clinical trials were conducted, 176 "Phase 2" clinical trials and 161 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 176Phase 2: 176Phase 3: 161Phase 3: 161Phase 1: 20Phase 1: 20Not Applicable: 8Not Applicable: 8Early Phase 1: 1Early Phase 1: 1

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 138Active, not recruiting: 138Recruiting: 89Recruiting: 89Completed: 88Completed: 88Terminated: 16Terminated: 16Suspended: 9Suspended: 9Unknown status: 3Unknown status: 3